Drug

Sovateltide clinical trials

Also written PMZ-1620 and IRL-1620.

studies test it: 11
open now: 4
in phase 3: 3
first study started: 2008

How each study uses sovateltide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the sovateltide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Approvals

The first approval found in each region, with its record

United States: Not in FDA's approval records
European Union: Not in EMA's list of EU-wide authorisations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Sovateltide: 3
PMZ-1620 along with standard treatment: 2
Sovateltide (IRL-1620) along with standard treatment: 2
PMZ-1620 (sovateltide) along with standard treatment: 2

Development codes

PMZ-1620: 4
IRL-1620: 3
SPI-1620: 3

Studies by the year they started

11 studies that test it; most in 2013 (2)

Studies that test sovateltide, by start year
Year	Studies
2008	1
2013	2
2018	2
2019	2
2023	1
2024	1
2025	1
2026	1

By phase

A phase 1/2 study counts in both.

Phase 1: 1
Phase 2: 6
Phase 3: 3
Phase 4: 1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Stroke: 2
Cerebral Infarction: 1
Alzheimer Disease: 1
Carcinoma: 1
Brain Injuries, Traumatic: 1
Ischemic Stroke: 1
Hypoxia-Ischemia, Brain: 1
Carcinoma, Non-Small-Cell Lung: 1

Who runs them

Industry 11 · Other 0

Pharmazz, Inc. (8) · Spectrum Pharmaceuticals, Inc (3)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 3, 1 in phase 3

Studies that test sovateltide, phase 3 first.

Sep 2027Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic StrokePhase 3 · Pharmazz, Inc.
Nov 2026Assess Safety and Efficacy of Sovateltide in Hypoxic-ischemic EncephalopathyPhase 2 · Pharmazz, Inc.
Dec 2026Study to Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic StrokePhase 4 · Pharmazz, Inc.

Studies

Open first, then newest update. How each study uses sovateltide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 11

Codes

What other systems call sovateltide · ClinicalTrials.gg INT003628

MeSH (NLM) C074308sovateltideConfirmed ClinicalTrials.gov, NLM
UNII (FDA) 11X778QIZSSOVATELTIDEConfirmed FDA, NLM
NCI Thesaurus C74027SovateltideOne source FDA

System	Code	Name there	Checked by
MeSH (NLM)	C074308	sovateltide	Confirmed ClinicalTrials.gov, NLM
UNII (FDA)	11X778QIZS	SOVATELTIDE	Confirmed FDA, NLM
NCI Thesaurus	C74027	Sovateltide	One source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.